Autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the diabetic mouse hindlimb

Vincenzo Sica, Sharon Williams-Ignarro, Filomena De Nigris, Francesco P. D'Armiento, Lilach O Lerman, Maria Luisa Balestrieri, Ciro Maione, Antonio Palagiano, Luigi Rossiello, Louis J. Ignarro, Claudio Napoli

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Peripheral arterial disease (PAD) is a major health problem especially when associated to diabetes. Administration of autologous bone marrow cells (BMC) is emerging as a novel intervention to induce therapeutic angiogenesis in experimental ischemic limb models and in patients with PAD. Since tissue ischemia and diabetes are associated with an overwhelming generation of oxygen radicals and detrimental effects due to formation of glycosylation end-products, metabolic intervention with antioxidants and L-arginine can confer beneficial effects beyond those achieved by BMC alone. The effects of cotreatment with intravenous BMCs and metabolic vascular protection (1.0% vitamin E, 0.05% vitamin C, and 6% L-arginine) were examined in the ischemic hindlimb of diabetic and non diabetic mice. BMC therapy increased blood flow and capillary densities and Ki67 proliferative marker, and decreased interstitial fibrosis. This effect was amplified by metabolic cotreatment, an intervention inducing vascular protection, at least in part, through the nitric oxide pathway, reduction of systemic oxidative stress, and macrophage activation.

Original languageEnglish (US)
Pages (from-to)2903-2908
Number of pages6
JournalCell Cycle
Volume5
Issue number24
StatePublished - Dec 15 2006

Fingerprint

Hindlimb
Medical problems
Cell- and Tissue-Based Therapy
Bone Marrow Cells
Bone
Ischemia
Peripheral Arterial Disease
Cells
Blood Vessels
Arginine
Glycosylation
Oxidative stress
Macrophage Activation
Macrophages
Vitamin E
Ascorbic Acid
Reactive Oxygen Species
Nitric Oxide
Oxidative Stress
Fibrosis

Keywords

  • Bone marrow cell
  • Diabetes
  • Ischemic hindlimb
  • L-arginine; antioxidants
  • Nitric oxide
  • Peripheral arterial disease

ASJC Scopus subject areas

  • Cell Biology
  • Biochemistry
  • Molecular Biology

Cite this

Sica, V., Williams-Ignarro, S., De Nigris, F., D'Armiento, F. P., Lerman, L. O., Balestrieri, M. L., ... Napoli, C. (2006). Autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the diabetic mouse hindlimb. Cell Cycle, 5(24), 2903-2908.

Autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the diabetic mouse hindlimb. / Sica, Vincenzo; Williams-Ignarro, Sharon; De Nigris, Filomena; D'Armiento, Francesco P.; Lerman, Lilach O; Balestrieri, Maria Luisa; Maione, Ciro; Palagiano, Antonio; Rossiello, Luigi; Ignarro, Louis J.; Napoli, Claudio.

In: Cell Cycle, Vol. 5, No. 24, 15.12.2006, p. 2903-2908.

Research output: Contribution to journalArticle

Sica, V, Williams-Ignarro, S, De Nigris, F, D'Armiento, FP, Lerman, LO, Balestrieri, ML, Maione, C, Palagiano, A, Rossiello, L, Ignarro, LJ & Napoli, C 2006, 'Autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the diabetic mouse hindlimb', Cell Cycle, vol. 5, no. 24, pp. 2903-2908.
Sica V, Williams-Ignarro S, De Nigris F, D'Armiento FP, Lerman LO, Balestrieri ML et al. Autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the diabetic mouse hindlimb. Cell Cycle. 2006 Dec 15;5(24):2903-2908.
Sica, Vincenzo ; Williams-Ignarro, Sharon ; De Nigris, Filomena ; D'Armiento, Francesco P. ; Lerman, Lilach O ; Balestrieri, Maria Luisa ; Maione, Ciro ; Palagiano, Antonio ; Rossiello, Luigi ; Ignarro, Louis J. ; Napoli, Claudio. / Autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the diabetic mouse hindlimb. In: Cell Cycle. 2006 ; Vol. 5, No. 24. pp. 2903-2908.
@article{0d0a10bc7d884e06b4f5f6c408c78a43,
title = "Autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the diabetic mouse hindlimb",
abstract = "Peripheral arterial disease (PAD) is a major health problem especially when associated to diabetes. Administration of autologous bone marrow cells (BMC) is emerging as a novel intervention to induce therapeutic angiogenesis in experimental ischemic limb models and in patients with PAD. Since tissue ischemia and diabetes are associated with an overwhelming generation of oxygen radicals and detrimental effects due to formation of glycosylation end-products, metabolic intervention with antioxidants and L-arginine can confer beneficial effects beyond those achieved by BMC alone. The effects of cotreatment with intravenous BMCs and metabolic vascular protection (1.0{\%} vitamin E, 0.05{\%} vitamin C, and 6{\%} L-arginine) were examined in the ischemic hindlimb of diabetic and non diabetic mice. BMC therapy increased blood flow and capillary densities and Ki67 proliferative marker, and decreased interstitial fibrosis. This effect was amplified by metabolic cotreatment, an intervention inducing vascular protection, at least in part, through the nitric oxide pathway, reduction of systemic oxidative stress, and macrophage activation.",
keywords = "Bone marrow cell, Diabetes, Ischemic hindlimb, L-arginine; antioxidants, Nitric oxide, Peripheral arterial disease",
author = "Vincenzo Sica and Sharon Williams-Ignarro and {De Nigris}, Filomena and D'Armiento, {Francesco P.} and Lerman, {Lilach O} and Balestrieri, {Maria Luisa} and Ciro Maione and Antonio Palagiano and Luigi Rossiello and Ignarro, {Louis J.} and Claudio Napoli",
year = "2006",
month = "12",
day = "15",
language = "English (US)",
volume = "5",
pages = "2903--2908",
journal = "Cell Cycle",
issn = "1538-4101",
publisher = "Landes Bioscience",
number = "24",

}

TY - JOUR

T1 - Autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the diabetic mouse hindlimb

AU - Sica, Vincenzo

AU - Williams-Ignarro, Sharon

AU - De Nigris, Filomena

AU - D'Armiento, Francesco P.

AU - Lerman, Lilach O

AU - Balestrieri, Maria Luisa

AU - Maione, Ciro

AU - Palagiano, Antonio

AU - Rossiello, Luigi

AU - Ignarro, Louis J.

AU - Napoli, Claudio

PY - 2006/12/15

Y1 - 2006/12/15

N2 - Peripheral arterial disease (PAD) is a major health problem especially when associated to diabetes. Administration of autologous bone marrow cells (BMC) is emerging as a novel intervention to induce therapeutic angiogenesis in experimental ischemic limb models and in patients with PAD. Since tissue ischemia and diabetes are associated with an overwhelming generation of oxygen radicals and detrimental effects due to formation of glycosylation end-products, metabolic intervention with antioxidants and L-arginine can confer beneficial effects beyond those achieved by BMC alone. The effects of cotreatment with intravenous BMCs and metabolic vascular protection (1.0% vitamin E, 0.05% vitamin C, and 6% L-arginine) were examined in the ischemic hindlimb of diabetic and non diabetic mice. BMC therapy increased blood flow and capillary densities and Ki67 proliferative marker, and decreased interstitial fibrosis. This effect was amplified by metabolic cotreatment, an intervention inducing vascular protection, at least in part, through the nitric oxide pathway, reduction of systemic oxidative stress, and macrophage activation.

AB - Peripheral arterial disease (PAD) is a major health problem especially when associated to diabetes. Administration of autologous bone marrow cells (BMC) is emerging as a novel intervention to induce therapeutic angiogenesis in experimental ischemic limb models and in patients with PAD. Since tissue ischemia and diabetes are associated with an overwhelming generation of oxygen radicals and detrimental effects due to formation of glycosylation end-products, metabolic intervention with antioxidants and L-arginine can confer beneficial effects beyond those achieved by BMC alone. The effects of cotreatment with intravenous BMCs and metabolic vascular protection (1.0% vitamin E, 0.05% vitamin C, and 6% L-arginine) were examined in the ischemic hindlimb of diabetic and non diabetic mice. BMC therapy increased blood flow and capillary densities and Ki67 proliferative marker, and decreased interstitial fibrosis. This effect was amplified by metabolic cotreatment, an intervention inducing vascular protection, at least in part, through the nitric oxide pathway, reduction of systemic oxidative stress, and macrophage activation.

KW - Bone marrow cell

KW - Diabetes

KW - Ischemic hindlimb

KW - L-arginine; antioxidants

KW - Nitric oxide

KW - Peripheral arterial disease

UR - http://www.scopus.com/inward/record.url?scp=33845620251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845620251&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 2903

EP - 2908

JO - Cell Cycle

JF - Cell Cycle

SN - 1538-4101

IS - 24

ER -